According to the results of a single-center, prospective, crossover study, darbepoetin alfa—a hyperglycosylated, and therefore longer-acting, derivative of epoetin—is a more effective ...
Study patients received subcutaneous darbepoetin alfa 6.75 ... Although they are effective, thrice-weekly or weekly regimens of epoetin alfa can pose an economic burden on patients with persistent ...
Purpose: The cost of darbepoetin alfa versus that of epoetin alfa in a hospital setting was studied. Methods: The study was an observational, retrospective review of the hospitalwide use of ...
It also offers less frequent dosing, given as a subcutaneous injection once every ... and concurrent haemoglobin increase compared to epoetin alfa," he added. BMS is also testing Reblozyl in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results